IRBESARTAN 150 MG TABLET

Irbesartan
$0.1103per EA

Strength

150 mg/1

Manufacturer

AvPAK

NDC

50268044115

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

IRBESARTAN

Approval Type

Generic (ANDA)

FDA Application

ANDA202910

On Market Since

8/8/2023

Pharmacological Classes

Angiotensin 2 Receptor Antagonists
Angiotensin 2 Receptor Blocker

Price History

1W

0.0%

1M

-1.2%

3M

-3.9%

6M

-4.1%

1Y

-10.7%

3Y

-60.3%

5Y

-60.3%

All

-31.5%